Cargando…
Validation of a method to assess emphysema severity by spirometry in the COPDGene study
BACKGROUND: Standard spirometry cannot identify the predominant mechanism underlying airflow obstruction in COPD, namely emphysema or airway disease. We aimed at validating a previously developed methodology to detect emphysema by mathematical analysis of the maximal expiratory flow-volume (MEFV) cu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195744/ https://www.ncbi.nlm.nih.gov/pubmed/32357885 http://dx.doi.org/10.1186/s12931-020-01366-4 |
_version_ | 1783528600016781312 |
---|---|
author | Occhipinti, Mariaelena Paoletti, Matteo Crapo, James D. Make, Barry J. Lynch, David A. Brusasco, Vito Lavorini, Federico Silverman, Edwin K. Regan, Elizabeth A. Pistolesi, Massimo |
author_facet | Occhipinti, Mariaelena Paoletti, Matteo Crapo, James D. Make, Barry J. Lynch, David A. Brusasco, Vito Lavorini, Federico Silverman, Edwin K. Regan, Elizabeth A. Pistolesi, Massimo |
author_sort | Occhipinti, Mariaelena |
collection | PubMed |
description | BACKGROUND: Standard spirometry cannot identify the predominant mechanism underlying airflow obstruction in COPD, namely emphysema or airway disease. We aimed at validating a previously developed methodology to detect emphysema by mathematical analysis of the maximal expiratory flow-volume (MEFV) curve in standard spirometry. METHODS: From the COPDGene population we selected those 5930 subjects with MEFV curve and inspiratory-expiratory CT obtained on the same day. The MEFV curve descending limb was fit real-time using forced vital capacity (FVC), peak expiratory flow, and forced expiratory flows at 25, 50 and 75% of FVC to derive an emphysema severity index (ESI), expressed as a continuous positive numeric parameter ranging from 0 to 10. According to inspiratory CT percent lung attenuation area below − 950 HU we defined three emphysema severity subgroups (%LAA(-950insp) < 6, 6–14, ≥14). By co-registration of inspiratory-expiratory CT we quantified persistent (%pLDA) and functional (%fLDA) low-density areas as CT metrics of emphysema and airway disease, respectively. RESULTS: ESI differentiated CT emphysema severity subgroups increasing in parallel with GOLD stages (p < .001), but with high variability within each stage. ESI had significantly higher correlations (p < .001) with emphysema than with airway disease CT metrics, explaining 67% of %pLDA variability. Conversely, standard spirometric variables (FEV(1), FEV(1)/FVC) had significantly lower correlations than ESI with emphysema CT metrics and did not differentiate between emphysema and airways CT metrics. CONCLUSIONS: ESI adds to standard spirometry the power to discriminate whether emphysema is the predominant mechanism of airway obstruction. ESI methodology has been validated in the large multiethnic population of smokers of the COPDGene study and therefore it could be applied for clinical and research purposes in the general population of smokers, using a readily available online website. |
format | Online Article Text |
id | pubmed-7195744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71957442020-05-06 Validation of a method to assess emphysema severity by spirometry in the COPDGene study Occhipinti, Mariaelena Paoletti, Matteo Crapo, James D. Make, Barry J. Lynch, David A. Brusasco, Vito Lavorini, Federico Silverman, Edwin K. Regan, Elizabeth A. Pistolesi, Massimo Respir Res Research BACKGROUND: Standard spirometry cannot identify the predominant mechanism underlying airflow obstruction in COPD, namely emphysema or airway disease. We aimed at validating a previously developed methodology to detect emphysema by mathematical analysis of the maximal expiratory flow-volume (MEFV) curve in standard spirometry. METHODS: From the COPDGene population we selected those 5930 subjects with MEFV curve and inspiratory-expiratory CT obtained on the same day. The MEFV curve descending limb was fit real-time using forced vital capacity (FVC), peak expiratory flow, and forced expiratory flows at 25, 50 and 75% of FVC to derive an emphysema severity index (ESI), expressed as a continuous positive numeric parameter ranging from 0 to 10. According to inspiratory CT percent lung attenuation area below − 950 HU we defined three emphysema severity subgroups (%LAA(-950insp) < 6, 6–14, ≥14). By co-registration of inspiratory-expiratory CT we quantified persistent (%pLDA) and functional (%fLDA) low-density areas as CT metrics of emphysema and airway disease, respectively. RESULTS: ESI differentiated CT emphysema severity subgroups increasing in parallel with GOLD stages (p < .001), but with high variability within each stage. ESI had significantly higher correlations (p < .001) with emphysema than with airway disease CT metrics, explaining 67% of %pLDA variability. Conversely, standard spirometric variables (FEV(1), FEV(1)/FVC) had significantly lower correlations than ESI with emphysema CT metrics and did not differentiate between emphysema and airways CT metrics. CONCLUSIONS: ESI adds to standard spirometry the power to discriminate whether emphysema is the predominant mechanism of airway obstruction. ESI methodology has been validated in the large multiethnic population of smokers of the COPDGene study and therefore it could be applied for clinical and research purposes in the general population of smokers, using a readily available online website. BioMed Central 2020-05-01 2020 /pmc/articles/PMC7195744/ /pubmed/32357885 http://dx.doi.org/10.1186/s12931-020-01366-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Occhipinti, Mariaelena Paoletti, Matteo Crapo, James D. Make, Barry J. Lynch, David A. Brusasco, Vito Lavorini, Federico Silverman, Edwin K. Regan, Elizabeth A. Pistolesi, Massimo Validation of a method to assess emphysema severity by spirometry in the COPDGene study |
title | Validation of a method to assess emphysema severity by spirometry in the COPDGene study |
title_full | Validation of a method to assess emphysema severity by spirometry in the COPDGene study |
title_fullStr | Validation of a method to assess emphysema severity by spirometry in the COPDGene study |
title_full_unstemmed | Validation of a method to assess emphysema severity by spirometry in the COPDGene study |
title_short | Validation of a method to assess emphysema severity by spirometry in the COPDGene study |
title_sort | validation of a method to assess emphysema severity by spirometry in the copdgene study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195744/ https://www.ncbi.nlm.nih.gov/pubmed/32357885 http://dx.doi.org/10.1186/s12931-020-01366-4 |
work_keys_str_mv | AT occhipintimariaelena validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT paolettimatteo validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT crapojamesd validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT makebarryj validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT lynchdavida validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT brusascovito validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT lavorinifederico validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT silvermanedwink validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT reganelizabetha validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy AT pistolesimassimo validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy |